We Can Medicines Co., Ltd. (6929.TWO)

TWD 37.5

(0.0%)

EBITDA Summary of We Can Medicines Co., Ltd.

  • We Can Medicines Co., Ltd.'s latest annual EBITDA in 2023 was 321.24 Million TWD , down -19.83% from previous year.
  • We Can Medicines Co., Ltd.'s latest quarterly EBITDA in 2024 Q2 was 76.45 Million TWD , down -20.19% from previous quarter.
  • We Can Medicines Co., Ltd. reported an annual EBITDA of 393.76 Million TWD in 2022, up 48.91% from previous year.
  • We Can Medicines Co., Ltd. reported an annual EBITDA of 266.98 Million TWD in 2021, up 5.37% from previous year.
  • We Can Medicines Co., Ltd. reported a quarterly EBITDA of 95.76 Million TWD for 2024 Q1, up 12.26% from previous quarter.
  • We Can Medicines Co., Ltd. reported a quarterly EBITDA of 82.9 Million TWD for 2023 Q4, up 17.05% from previous quarter.

Annual EBITDA Chart of We Can Medicines Co., Ltd. (2023 - 2020)

Historical Annual EBITDA of We Can Medicines Co., Ltd. (2023 - 2020)

Year EBITDA EBITDA Growth
2023 321.24 Million TWD -19.83%
2022 393.76 Million TWD 48.91%
2021 266.98 Million TWD 5.37%
2020 253.52 Million TWD 0.0%

Peer EBITDA Comparison of We Can Medicines Co., Ltd.

Name EBITDA EBITDA Difference
Tehmag Foods Corporation 1.1 Billion TWD 70.944%
SunWay Biotech Co., LTD. 83.46 Million TWD -284.878%
Hantech Bio-Technology Co., Ltd. 198.26 Million TWD -62.026%
Lian Fa International Dining Business Corp. 187.19 Million TWD -71.612%
Jia Jie Biomedical Co., Ltd. 161.78 Million TWD -98.565%
Microbio Co., Ltd. -261.3 Million TWD 222.939%
Chung Hwa Food Industrial Co., Ltd. 461.41 Million TWD 30.378%
DaBomb Protein Biotech Corp. -25.99 Million TWD 1335.704%
Far East Bio-Tec Co., Ltd. 49.07 Million TWD -554.562%
Wonder Pets Enterprises Corporation 404.28 Million TWD 20.539%
Eagle Cold Storage Enterprise Co., Ltd. 374.67 Million TWD 14.26%